A new artificial intelligence-based imaging tool has demonstrated the ability to predict future cardiovascular events in patients suffering from angina. This significant development was announced during...
The use of GLP-1 medications has expanded significantly, with patients increasingly seeking benefits beyond weight loss. These drugs, including the well-known Ozempic, initially prescribed for type...
Researchers from the University of Eastern Finland have reported a promising advancement in gene therapy aimed at treating patients suffering from refractory angina, a severe form...
